Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × brivanib × Clear all

NCT04395612 2021-05-21

CQGOG0101

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT01267253 2019-03-20

Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer

Phase 2 Completed

31 enrolled 9 charts

Uterine Cervical Neoplasms